ASP Isotopes Inc. (ASPI) - Forward P/S Multiple
The projected P/S dynamics demonstrate a current trend where the value is maintained at 9.30. ASP Isotopes Inc. (ASPI) is implementing advanced isotope separation methods for quantum systems and HALEU. Management possesses unique expertise in laser technologies, ensuring transparency of plans. Developments in the US and South Africa target the energy and medical sectors, guaranteeing sustainable demand.
Analytical breakdowns for ASP Isotopes Group (ASPI)
- stock price and consensus target price:
- market capitalization indicators:
- issuer book value statistics:
- company liabilities and liquidity data:
Total Debt to Equity Ratio ASP Isotopes Inc.|ASPI - Long-Term Loans to Capital Ratio|Short-Term Debt to Equity ASP Isotopes Inc.|ASPI - Company Cumulative Debt|Debt to Book Capitalization Ratio ASP Isotopes Group|ASPI - Long-Term Liabilities|Company Short-Term Debts ASP Isotopes|Quick Liquidity aspisotopes.com
- business earnings and investment ratios data:
ASPI - Net Financial Result|Future Profit ASP Isotopes Inc.|ASPI - Company Value to Net Income|Forward P/E Multiple ASP Isotopes Corp|ASPI - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization ASP Isotopes Group|ASPI - Operating profit before amortization|Net earnings per share (EPS TTM) ASP Isotopes|ASPI - Net earnings per share for the last 12 months|Year-over-year net earnings per share growth for the last 12 months aspisotopes.com|ASPI - Expected net earnings per share growth this year|Earnings growth forecast for next year ASP Isotopes Inc.
- sales volume and revenue indicators:
Initial company analysis:ASPI (ASP Isotopes)
For ASP Isotopes Inc. (ASPI), which is currently in the capacity deployment phase for isotope separation, market valuation based on future sales is critical. The company's forward P/S reflects the ratio of current market capitalization to projected revenue, determining the premium level for its technological potential. The dynamics of this indicator allow for a comparison between investor expectations and the actual pace of commercializing nuclear innovations. An increase in this metric without confirmation from new contracts signals an overvaluation of assets.
Direct competitors
Linde - Forward Price-to-Revenue Multiple|Forward Price to Sales APD|E. I. du Pont de Nemours and Company - Forward P/S Multiple|Market Cap to Expected Sales Ratio IP Corp IP|ppg.com (PPG) - Price-to-Projected Revenue Ratio|DOW - Market Cap to Expected Sales Ratio|Price-to-Projected Revenue Ratio LyondellBasell|Market Cap to Future Revenue Ratio IFF Inc. IFF|Forward Price-to-Revenue Multiple RPM (RPM Corp)|Price to Expected Revenue Ratio ENTG|Price-to-Projected Revenue Ratio Suzano S.A. SUZ|westlake.com (WLK) - Market Cap to Future Revenue Ratio|ALB - Price-to-Projected Revenue Ratio|Future Price to Revenue ICL|NEU: Forward P/S Multiple|Market Cap to Future Revenue Ratio Eastman Kodak Chemical (EMN)|Price-to-Projected Revenue Ratio Axalta Coating Systems|elementsolutionsinc.com (ESI) - Market Cap to Expected Sales Ratio|Forward Price-to-Revenue Multiple SQM (Sociedad Química y Minera de Chile)|CE (Celanese Corp) - Forward Price to Sales|Forward P/S Multiple SXT (Sensient Corp)|Market Cap to Expected Sales Ratio Cabot Chemicals (CBT)|HWKN - Price-to-Projected Revenue Ratio|AVNT (avient.com) - Market Cap to Projected Revenue|FUL: Forward P/S Multiple|Forward Price-to-Revenue Multiple Methanex Corp|Forward Price-to-Revenue Multiple WDFC|Chemours Co. (CC) - Market Cap to Expected Sales Ratio|Forward P/S Multiple KWR|Forward P/S Multiple purecycletech.com (PCT)|Price-to-Projected Revenue Ratio Ashland ASH|Market Cap to Expected Sales Ratio Ingevity Corp (NGVT)|IOSP - Price-to-Projected Revenue Ratio|Future Price to Revenue MTX|DQ: Forward P/S Multiple|SLVM - Market Cap to Expected Sales Ratio|HUN (Huntsman) - Forward P/S Multiple|Forward Price-to-Revenue Multiple Albany International Corp (AIN)|Forward P/S Multiple CLMT|ROG (Rogers Materials) - Forward Price to Sales|Forward P/S Multiple SCL (Stepan Company)|ecovyst.com (ECVT) - Market Cap to Future Revenue Ratio|NEO - Price-to-Projected Revenue Ratio|REX American Resources Corp (REX) - Forward Price-to-Revenue Multiple|TROX: Forward P/S Multiple|GSM - Market Cap to Expected Sales Ratio|Price-to-Projected Revenue Ratio Westlake Chemical Partners|compassminerals.com (CMP) - Market Cap to Expected Sales Ratio|Forward Price-to-Revenue Multiple KRO (Kronos Worldwide)|Price to Expected Revenue Ratio MATV|Price-to-Projected Revenue Ratio LSB Corp LXU|Forward Price to Sales BAK|KOP: Forward Price-to-Revenue Multiple|Market Cap to Future Revenue Ratio advansix.com|OEC: Forward P/S Multiple|Rayonier Advanced Materials Inc. (RYAM) - Forward P/S Multiple|Price-to-Projected Revenue Ratio Aduro Corp|Magnera Group (MAGN) - Market Cap to Expected Sales Ratio|Price-to-Projected Revenue Ratio Clearwater Paper (CLW)|TG: Future Price to Revenue|Core Molding Technologies, Inc. - Forward Price-to-Revenue Multiple|Forward Price to Sales FF|Flexible Solutions International, Inc. - Forward P/S Multiple|Market Cap to Expected Sales Ratio Alto Ingredients, Inc. ALTO|5eadvancedmaterials.com (FEAM) - Price-to-Projected Revenue Ratio|TSE - Market Cap to Expected Sales Ratio|Price-to-Projected Revenue Ratio Origin Materials Inc|Market Cap to Future Revenue Ratio Northern Technologies International Corporation NTIC|Forward Price-to-Revenue Multiple LNZA (LanzaTech Global Inc)|Price to Expected Revenue Ratio YMAT|Price-to-Projected Revenue Ratio New Era Helium NUAI|boltthreads.com (BSLK) - Market Cap to Future Revenue Ratio|BGLC - Price-to-Projected Revenue Ratio|Future Price to Revenue GURE|CNEY: Forward P/S Multiple|Market Cap to Future Revenue Ratio Arcadium Lithium (ALTM)|Price-to-Projected Revenue Ratio Danimer Scientific|Glatfelter Corp. (GLT) - Market Cap to Expected Sales Ratio|Forward Price-to-Revenue Multiple GRFX (Graphex Group Limited)|SLCA (U.S. Silica Holdings, Inc.) - Forward Price to Sales|Forward P/S Multiple IZTC (Invizyne)
